Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has pioneered an enabling technology that enhances the body’s absorption of cannabinoids.
Marijuana Industry
PotNetwork Holding, Inc. (POTN) Subsidiary Reports Revenues in Excess of $1.6M for November
PotNetwork Holding, Inc. (OTC: POTN), through wholly-owned subsidiary Diamond CBD, Inc., this morning reported revenues exceeding $1.6 million for the month of November.
Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) Aims to Enhance Opioid Analgesic Effects with Specific Cannabis Strain
On September 13, 2017, Cannevert Therapeutics Ltd. (“CTL”), the research arm of Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP), filed a provisional patent for the use of a specific strain of cannabis to enhance the actions of opioid analgesics.
Marijuana Company of America (MCOA) Subsidiary Poised for Breakthrough with CBD-based Wellness Products
Marijuana Company of America, Inc. (OTC: MCOA), via its wholly-owned subsidiary hempSMART, is well positioned to take advantage of this industry growth through the development and marketing of innovative hemp-derived, CBD-based nutritional and wellness products.
Purified Cannabinoids Open New Opportunities in Pain Management
In Canada, chronic pain affects 1.5 million people. As national and worldwide numbers in pain diagnoses continue to rise, innovators in the cannabis industry are developing promising therapies to address this growing market.
Bitcoin’s Rise Solidifies the Intersection of Cannabis and Cryptocurrency
One area of the industry that appears to offer significant growth potential is the application of bitcoin and other cryptocurrencies to sectors of the economy, such as the cannabis industry.
Skinvisible, Inc. (SKVI) Maximizes Product Development Opportunities with Global Goals
Research and development company Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI), continues to add significant value to its core business model with several key movements involving a proposed merger, new licensing agreements and formation of a specialized subsidiary.
Study: U.S. Marijuana Legalization Would Create a Million New Jobs, $132 Billion in Tax Revenue in First 8 Years - From Washington Post
Legalizing marijuana nationwide would create at least $132 billion in tax revenue and more than a million new jobs across the United States in the next decade, according to a new study.
Cultivating the Cannabis Lifestyle: Canadian Cannabis Players Gear Up for Recreational Marijuana Legalization
The turning tide in public sentiment and the advancement of legalization, both in Canada and throughout the world, are gradually destigmatizing marijuana use and giving rise to new cannabis subcultures and brands.
BBC Capital - Meet Canada’s ‘weed sommelier’
Rade Kovacevic is a cannabis connoisseur. As the head of customer experience at Canopy Growth Corporation, a cannabis producer in Ontario, Canada, his job is to make sure his firm provides the highest quality marijuana. His company produces medicinal cannabis for patients across Canada, where recreational use is illegal but doctors can prescribe it to patients for medical purposes, such as pain management.
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Partners with Stakeholders to Participate on Global Scale with DehydraTECH™
Amidst increasing awareness regarding cannabinoids and their potential health benefits, Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) is at the forefront of the booming cannabis industry with its patented delivery technology, DehydraTECH™.
Companies Offer Intriguing Investment Opportunities as Bitcoin Continues Smashing Records
Various enterprising companies emerging within the marketplace are providing promising ancillary investment options for those seeking to cash in on bitcoin’s rising star without investing directly in it.
Why Medical Cannabis Payment Solutions (REFG) is “One to Watch”
Medical Cannabis Payment Solutions is intent on opening the bottleneck with its proprietary merchant processing system designed to serve the monetary demands of the state-legalized cannabis market.
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Boosts Revenue by Out-Licensing Patented Technology to Third-Party Partners
Lexaria generates revenue by out-licensing its patented global technology related to ingestion of edible cannabinoids at a rate of 5-10% of gross sales to its third-party partners.
PotNetwork Holding Inc. (POTN) Positioned for a Bright Future in the CBD Market
PotNetwork Holding, Inc. (OTC: POTN) is in a strong position to take advantage of this market growth through its subsidiary, Diamond CBD.